Juvena Therapeutics
PrivateLast Round
Series B
Jan 12, 2026
Est. Valuation
$111M
Total Funding Raised
$131.16M
Momentum Score
25 /100
Company Overview
Juvena Therapeutics is a biopharmaceutical company focused on developing a drug discovery platform that identifies innovative protein-based therapeutics aimed at promoting tissue regeneration and repair for chronic and rare diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Medical AI, ML Platforms
Business Model
B2B
Customer Profile
Revenue Share, Services & Consulting, Government Contracts
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Juvena Therapeutics Comps
Public and private peers based on sector, stage, and business model.
Juvena Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B | Jan 12, 2026 | ||||
| Series B | Jul 24, 2025 | ||||
| Series A | Nov 8, 2022 | ||||
| Grant | Feb 2, 2022 | ||||
| Grant | Aug 1, 2021 |
Juvena Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Horizons Ventures | Series B, Series A |
| NIH RADx | Grant |
| Plum Alley Investments | Series A |
| Intersect VC | Series A |
| Intersect Capital | Series A |
| Jefferson Life Sciences | Series B |
| California Institute for Regenerative Medicine | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jan 12, 2026
$34M round completed.
- Aug 12, 2025
Candidate JUV-112 is currently in lead optimization.
Juvena Therapeutics Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Juvena Therapeutics's valuation, stock price, and market status.
